Pediatric Hematology and Oncology

Central Line-Associated Bloodstream Infections

To avoid central line-associated bloodstream infections (CLABSIs), healthcare providers must follow a strict protocol when inserting the line and stringent infection control practices each time they check the line or change the dressing.¹

Non-Mucosal Barrier Central Line-Associated Bloodstream Infections

2016 - 2018

CL = central line, NHSN = National Healthcare Safety Network

ᵃ National Healthcare Safety Network 2016 - 2017 benchmark for central line-associated bloodstream infections (CLABSI) is 2.1/1000 central line days for pediatric Hematology Oncology ward. NHSN no longer uses benchmarks for CLABSI rate.

Non-MBI CLABSI refers to a CLABSI that is not due to a mucosal barrier injury. This distinction is important in hematology/oncology where many of the patients are at risk for mucosal breakdown.

References

¹ Centers for Disease Control and Prevention. Central Line-associated Bloodstream Infections: Resources for Patients and Healthcare Providers. www.cdc.gov/hai/bsi/clabsi-resources.html. Updated Apr 1, 2010. Accessed Mar 19, 2018.